• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rs738409 C>G变异影响经活检证实的非酒精性脂肪性肝病中内脏脂肪与显著纤维化之间的关联。

rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.

作者信息

Li Gang, Tang Liang-Jie, Zhu Pei-Wu, Huang Ou-Yang, Rios Rafael S, Zheng Kenneth I, Chen Sui-Dan, Ma Hong-Lei, Targher Giovanni, Byrne Christopher D, Pan Xiao-Yan, Zheng Ming-Hua

机构信息

NAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

J Clin Transl Hepatol. 2022 Jun 28;10(3):439-448. doi: 10.14218/JCTH.2021.00286. Epub 2021 Oct 22.

DOI:10.14218/JCTH.2021.00286
PMID:35836754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9240254/
Abstract

BACKGROUND AND AIMS

Intra-abdominal visceral fat accumulation and patatin-like phospholipase domain containing 3 () rs738409 G/C gene polymorphism confer a greater susceptibility to nonalcoholic fatty liver disease (NAFLD). We examined whether the relationship between visceral fat accumulation and liver disease severity may be influenced by rs738409 polymorphism.

METHODS

The variant of rs738409 was genotyped within 523 Han individuals with biopsy-confirmed NAFLD. Visceral fat area (VFA) was measured by bioelectrical impedance. Significant liver fibrosis (SF), defined as stage F ≥2 on histology, was the outcome measure of interest.

RESULTS

The distribution of genotypes was CC: 27.5%, CG: 48.2%, and GG: 24.3%. Higher VFA was associated with greater risk of having SF (adjusted-odds ratio [OR]: 1.03; 95% confidence interval [CI]: 1.02-1.04, <0.05), independent of potential confounders. Among subjects with the same VFA level, the risk of SF was greater among carriers of the rs738409 G genotype than among those who did not. Stratified analysis showed that rs738409 significantly influenced the association between VFA and SF. VFA remained significantly associated with SF only among the rs738409 G-allele carriers (adjusted-OR: 1.05; 95% CI: 1.03-1.08 for the GG group; and adjusted-OR:1.03; 95% CI: 1.01-1.04 for the GC group). There was a significant interaction between VFA and rs738409 genotype (P =0.004).

CONCLUSIONS

rs738409 G allele has a moderate effect on the association between VFA and risk of SF in adult individuals with biopsy-proven NAFLD. Existence of the rs738409 G allele and VFA interact to increase risk of SF.

摘要

背景与目的

腹内内脏脂肪堆积以及含patatin样磷脂酶结构域3()rs738409 G/C基因多态性会增加非酒精性脂肪性肝病(NAFLD)的易感性。我们研究了内脏脂肪堆积与肝脏疾病严重程度之间的关系是否会受到rs738409多态性的影响。

方法

对523名经活检确诊为NAFLD的汉族个体进行rs738409变异的基因分型。通过生物电阻抗测量内脏脂肪面积(VFA)。显著肝纤维化(SF)定义为组织学分期F≥2,是感兴趣的结局指标。

结果

基因型分布为CC:27.5%,CG:48.2%,GG:24.3%。较高的VFA与发生SF的风险增加相关(校正比值比[OR]:1.03;95%置信区间[CI]:1.02 - 1.04,<0.05),独立于潜在混杂因素。在相同VFA水平的受试者中,rs738409 G基因型携带者发生SF的风险高于非携带者。分层分析表明,rs738409显著影响VFA与SF之间的关联。仅在rs738409 G等位基因携带者中,VFA与SF仍显著相关(GG组校正OR:1.05;95% CI:1.03 - 1.08;GC组校正OR:1.03;95% CI:1.01 - 1.04)。VFA与rs738409基因型之间存在显著交互作用(P = 0.004)。

结论

在经活检证实为NAFLD的成年个体中,rs738409 G等位基因对VFA与SF风险之间的关联有中度影响。rs738409 G等位基因的存在与VFA相互作用会增加SF风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/06a19ac33a3e/JCTH-10-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/6e2e9821fc97/JCTH-10-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/3f13726dfa83/JCTH-10-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/06a19ac33a3e/JCTH-10-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/6e2e9821fc97/JCTH-10-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/3f13726dfa83/JCTH-10-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e19b/9240254/06a19ac33a3e/JCTH-10-439-g003.jpg

相似文献

1
rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.rs738409 C>G变异影响经活检证实的非酒精性脂肪性肝病中内脏脂肪与显著纤维化之间的关联。
J Clin Transl Hepatol. 2022 Jun 28;10(3):439-448. doi: 10.14218/JCTH.2021.00286. Epub 2021 Oct 22.
2
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.载脂蛋白基因多态性与儿童非酒精性脂肪性肝病的关系: 荟萃分析。
BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8.
3
Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.载脂蛋白 L3 基因变异与饮食摄入对非酒精性脂肪性肝病患者发生显著纤维化风险的影响。
Am J Gastroenterol. 2021 May 1;116(5):994-1006. doi: 10.14309/ajg.0000000000001072.
4
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.PNPLA3基因rs738409多态性与非酒精性脂肪性肝病(NAFLD)易感性及严重程度的关联:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.
5
Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.PNPLA3 I148M基因多态性在韩国非酒精性脂肪性肝病和肝纤维化中的作用
Dig Dis Sci. 2014 Dec;59(12):2967-74. doi: 10.1007/s10620-014-3279-z. Epub 2014 Jul 29.
6
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.载脂蛋白基因 3 上 rs738409 多态性与肝损伤及非酒精性脂肪性肝病的发生相关。
BMC Med Genet. 2010 Dec 22;11:172. doi: 10.1186/1471-2350-11-172.
7
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease.载脂蛋白 L3 基因 rs738409C>G 变异与非酒精性脂肪性肝病患者肝脏相关结局的关系。
Clin Gastroenterol Hepatol. 2020 Apr;18(4):935-944.e3. doi: 10.1016/j.cgh.2019.08.011. Epub 2019 Aug 13.
8
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.载脂蛋白 PLA3 基因多态性对各种非侵入性标记物诊断和分期非酒精性脂肪性肝病的诊断性能的影响。
J Gastroenterol Hepatol. 2020 Jun;35(6):1057-1064. doi: 10.1111/jgh.14894. Epub 2019 Dec 9.
9
PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.过氧化物酶体增殖物激活受体 γ 辅激活因子 1α(PPARGC1A)rs8192678 G>A 多态性影响非酒精性脂肪性肝病患者肝组织学特征和非酒精性脂肪性肝炎的严重程度。
World J Gastroenterol. 2021 Jul 7;27(25):3863-3876. doi: 10.3748/wjg.v27.i25.3863.
10
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.载脂蛋白基因 3 多态性 rs738409 对非酒精性脂肪性肝病患者肝脏相关事件发生的影响。
Clin Gastroenterol Hepatol. 2023 Dec;21(13):3314-3321.e3. doi: 10.1016/j.cgh.2023.04.024. Epub 2023 May 4.

引用本文的文献

1
() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.越南劳动年龄成年人中 rs738409 变异与非酒精性脂肪性肝病风险:一项具有代谢见解的病例对照研究
Clin Exp Gastroenterol. 2025 Aug 29;18:191-204. doi: 10.2147/CEG.S532528. eCollection 2025.
2
MASLD development: From molecular pathogenesis toward therapeutic strategies.代谢相关脂肪性肝病的发展:从分子发病机制到治疗策略
Chin Med J (Engl). 2025 Aug 5;138(15):1807-1824. doi: 10.1097/CM9.0000000000003629. Epub 2025 Jul 10.
3
PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease.

本文引用的文献

1
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.性别影响经肝活检证实的非酒精性脂肪性肝病患者四肢骨骼肌与内脏脂肪面积比与非酒精性脂肪性肝炎之间的关联。
Br J Nutr. 2022 Jun 14;127(11):1613-1620. doi: 10.1017/S0007114521002415. Epub 2021 Jun 28.
2
Natural History of NAFLD.非酒精性脂肪性肝病的自然史
J Clin Med. 2021 Mar 10;10(6):1161. doi: 10.3390/jcm10061161.
3
Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes.
PNPLA3 I148M与环境触发因素相互作用导致人类疾病。
Liver Int. 2025 Mar;45(3):e16106. doi: 10.1111/liv.16106. Epub 2024 Nov 19.
4
Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD.PNPLA3 I148M对非酒精性脂肪性肝炎患者临床结局的影响
Liver Int. 2025 Mar;45(3):e16133. doi: 10.1111/liv.16133. Epub 2024 Oct 16.
内脏脂肪组织与 2 型糖尿病患者的非酒精性脂肪肝
Dig Dis Sci. 2022 Apr;67(4):1389-1398. doi: 10.1007/s10620-021-06953-z. Epub 2021 Mar 31.
4
Visceral fat area to appendicular muscle mass ratio as a predictor for nonalcoholic fatty liver disease independent of obesity.内脏脂肪面积与四肢骨骼肌质量比作为非酒精性脂肪肝独立于肥胖的预测指标。
Scand J Gastroenterol. 2021 Mar;56(3):312-320. doi: 10.1080/00365521.2021.1879244. Epub 2021 Feb 3.
5
When a new definition overhauls perceptions of MAFLD related cirrhosis care.当一个新定义彻底改变了对MAFLD相关肝硬化护理的认知时。
Hepatobiliary Surg Nutr. 2020 Dec;9(6):801-804. doi: 10.21037/hbsn-20-725.
6
Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease.内脏脂肪的评估对于非酒精性脂肪性肝病患者显著纤维化的诊断很有用。
World J Gastroenterol. 2020 Nov 14;26(42):6658-6668. doi: 10.3748/wjg.v26.i42.6658.
7
Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease.肌肉改变与非酒精性脂肪性肝病患者的显著纤维化独立相关。
Liver Int. 2021 Mar;41(3):494-504. doi: 10.1111/liv.14719. Epub 2020 Nov 20.
8
Cross talk between liver and adipose tissue: A new role for PNPLA3?
Liver Int. 2020 Sep;40(9):2074-2075. doi: 10.1111/liv.14561.
9
The PNPLA3-I148M variant increases polyunsaturated triglycerides in human adipose tissue.PNPLA3-I148M变异体增加了人体脂肪组织中的多不饱和甘油三酯。
Liver Int. 2020 Sep;40(9):2128-2138. doi: 10.1111/liv.14507. Epub 2020 May 18.
10
Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.非酒精性脂肪性肝病、2 型糖尿病和肥胖之间的因果关系对疾病亚表型有影响。
J Hepatol. 2020 Aug;73(2):263-276. doi: 10.1016/j.jhep.2020.03.006. Epub 2020 Mar 10.